Evidence map›Paper›PMID 25364823›Full record

ArticlePloS one2014

Using Bayes' rule to define the value of evidence from syndromic surveillance.

Mats Gunnar Andersson, Céline Faverjon, Flavie Vial, Loïc Legrand, Agnès Leblond

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Evaluation of a Multivariate Syndromic Surveillance System for West Nile Virus.Vector borne and zoonotic diseases (Larchmont, N.Y.) · 2016
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mats Gunnar AnderssonDepartment of Chemistry, Environment and Feed Hygiene, The National Veterinary Institute, Uppsala, Sweden.
Céline FaverjonINRA UR346 Animal Epidemiology, VetagroSup, Marcy L'Etoile, France.
Flavie VialVeterinary Public Health Institute, DCR-VPH, Vetsuisse Fakultät, Bern, Switzerland.
Loïc LegrandLABÉO - Frank Duncombe, Unité Risques Microbiens (U2RM), EA 4655, Normandie Universite, Caen, Normandy, France; Réseau d'EpidémioSurveillance en Pathologie Equine (RESPE), Caen, France.
Agnès LeblondRéseau d'EpidémioSurveillance en Pathologie Equine (RESPE), Caen, France; INRA UR346 Animal Epidemiology et Département Hippique, VetAgroSup, Marcy L'Etoile, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work we propose the adoption of a statistical framework used in the evaluation of forensic evidence as a tool for evaluating and presenting circumstantial "evidence" of a disease outbreak from syndromic surveillance. The basic idea is to exploit the predicted distributions of reported cases to calculate the ratio of the likelihood of observing n cases given an ongoing outbreak over the likelihood of observing n cases given no outbreak. The likelihood ratio defines the Value of Evidence (V). Using Bayes' rule, the prior odds for an ongoing outbreak are multiplied by V to obtain the posterior odds. This approach was applied to time series on the number of horses showing clinical respiratory symptoms or neurological symptoms. The separation between prior beliefs about the probability of an outbreak and the strength of evidence from syndromic surveillance offers a transparent reasoning process suitable for supporting decision makers. The value of evidence can be translated into a verbal statement, as often done in forensics or used for the production of risk maps. Furthermore, a Bayesian approach offers seamless integration of data from syndromic surveillance with results from predictive modeling and with information from other sources such as disease introduction risk assessments.

Indexed as

Bayes TheoremDisease OutbreaksPopulation SurveillanceAlgorithmsAnimal DiseasesAnimalsDecision MakingDogsForensic MedicineFranceHorses

Identifiers

PMID25364823
PMCPMC4218722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.